Actigen will discontinue operational activities, pending ongoing clinical trials at a partner and the market situation. There is an option of restarting the program if these clinical trials are successful and the market situation is favourable.
As such, Actigen will not engage in business or clinical operations. Further updates will be provided as clinical trial results are available.
